These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11296976)

  • 1. Rating of arthritis health states by patients, physicians, and the general public. Implications for cost-utility analyses.
    Suarez-Almazor ME; Conner-Spady B
    J Rheumatol; 2001 Mar; 28(3):648-56. PubMed ID: 11296976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S; Kristiansen IS; Kvien TK
    Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis.
    van den Hout WB; de Jong Z; Munneke M; Hazes JM; Breedveld FC; Vliet Vlieland TP
    Arthritis Rheum; 2005 Feb; 53(1):39-47. PubMed ID: 15696568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
    Witney AG; Treharne GJ; Tavakoli M; Lyons AC; Vincent K; Scott DL; Kitas GD
    Rheumatology (Oxford); 2006 Aug; 45(8):975-81. PubMed ID: 16461437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages and limitations of utility assessment methods in rheumatoid arthritis.
    Beresniak A; Russell AS; Haraoui B; Bessette L; Bombardier C; Duru G
    J Rheumatol; 2007 Nov; 34(11):2193-200. PubMed ID: 17937471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not all "quality-adjusted life years" are equal.
    Marra CA; Marion SA; Guh DP; Najafzadeh M; Wolfe F; Esdaile JM; Clarke AE; Gignac MA; Anis AH
    J Clin Epidemiol; 2007 Jun; 60(6):616-24. PubMed ID: 17493521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
    Kobelt G; Lindgren P; Singh A; Klareskog L
    Ann Rheum Dis; 2005 Aug; 64(8):1174-9. PubMed ID: 15708879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden.
    Söderlin MK; Kautiainen H; Skogh T; Leirisalo-Repo M
    J Rheumatol; 2004 Sep; 31(9):1717-22. PubMed ID: 15338489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population.
    Uhlig T; Loge JH; Kristiansen IS; Kvien TK
    J Rheumatol; 2007 Jun; 34(6):1241-7. PubMed ID: 17516624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK; Verburg RJ; Sont JK; van den Hout WB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Aug; 52(8):2272-6. PubMed ID: 16052541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of cochlear implants in Korea using different measures of utility.
    Lee HY; Park EC; Kim HJ; Choi JY; Kim HN
    Acta Otolaryngol; 2006 Aug; 126(8):817-23. PubMed ID: 16846923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
    Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
    Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.
    Harrison MJ; Davies LM; Bansback NJ; Ingram M; Anis AH; Symmons DP
    J Rheumatol; 2008 Apr; 35(4):592-602. PubMed ID: 18278841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.